Therapeutic Nanocatalysis to Slow Disease Progression of Amyotrophic Lateral Sclerosis (ALS)
Clinical trial NCT04098406 · COMPLETED
Trial details
- NCT number
- NCT04098406
- Sponsor
- Clene Nanomedicine
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-19
- Primary completion
- 2021-07-13
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.